Literature DB >> 7897699

Retinoic acid regulates the development of oligodendrocyte precursor cells in vitro.

P Laeng1, D Décimo, B Pettmann, T Janet, G Labourdette.   

Abstract

Cultures of oligodendrocyte precursor cells can be grown from brain hemispheres of newborn rats. These cells, also called O-2A progenitor cells, can differentiate in vitro into oligodendrocytes or type 2 astrocytes. Basic FGF and PDGF are known to stimulate their proliferation and delay their differentiation. Lack or excess of retinoic acid (RA) has been known for a long time to alter brain development suggesting that this compound is involved in normal brain development. Here we report that RA partially inhibits both the proliferation and the differentiation of oligodendrocyte precursor cells. It also down-regulates the mitogenic effect of bFGF on these cells while keeping them in an immature stage. RA is more effective than bFGF in inhibiting myelin basic protein mRNA expression in these cells, and like bFGF, it preserves their bipotential character. RA nuclear receptors RAR-alpha and their transcripts are expressed in oligodendrocyte precursor cells as seen by Western blot, Northern blot and in situ hybridization. The expression of RAR-alpha transcripts is stimulated transiently by RA alone or associated to bFGF. The expression of RAR-beta transcripts is not constitutive and is induced by RA alone or associated to bFGF and to a lesser extent by bFGF alone. These results suggest that retinoids participate in the control of the development of glial cells of the oligodendrocyte lineage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7897699     DOI: 10.1002/jnr.490390602

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  10 in total

1.  K+ channel expression and cell proliferation are regulated by intracellular sodium and membrane depolarization in oligodendrocyte progenitor cells.

Authors:  P Knutson; C A Ghiani; J M Zhou; V Gallo; C J McBain
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

Review 2.  Glial lineages and myelination in the central nervous system.

Authors:  A Compston; J Zajicek; J Sussman; A Webb; G Hall; D Muir; C Shaw; A Wood; N Scolding
Journal:  J Anat       Date:  1997-02       Impact factor: 2.610

Review 3.  Growth factors, glia and gliomas.

Authors:  M Noble; M Mayer-Pröschel
Journal:  J Neurooncol       Date:  1997-12       Impact factor: 4.130

Review 4.  Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology.

Authors:  Li-Jin Chew; Cynthia A DeBoy
Journal:  Neuropharmacology       Date:  2015-06-24       Impact factor: 5.250

5.  Expression of the gene for the POU domain transcription factor Tst-1/Oct6 is regulated by an estrogen-dependent enhancer.

Authors:  K Renner; E Sock; J R Bermingham; M Wegner
Journal:  Nucleic Acids Res       Date:  1996-11-15       Impact factor: 16.971

6.  Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation.

Authors:  J R Chan; L J Phillips; M Glaser
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  Temporal and spatial specificity of PDGF alpha receptor promoter in transgenic mice.

Authors:  K K Reinertsen; R T Bronson; C D Stiles; C Wang
Journal:  Gene Expr       Date:  1997

8.  Regulation of Myelination by Exosome Associated Retinoic Acid Release from NG2-Positive Cells.

Authors:  Maria B Goncalves; Yue Wu; Earl Clarke; John Grist; Carl Hobbs; Diogo Trigo; Julian Jack; Jonathan P T Corcoran
Journal:  J Neurosci       Date:  2019-02-13       Impact factor: 6.167

9.  Retinoic Acid Is Required for Oligodendrocyte Precursor Cell Production and Differentiation in the Postnatal Mouse Corpus Callosum.

Authors:  Vivianne E Morrison; Victoria N Smith; Jeffrey K Huang
Journal:  eNeuro       Date:  2020-01-22

10.  Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination.

Authors:  Jae Young Lee; Min Joung Kim; Devy Deliyanti; Michael F Azari; Fernando Rossello; Adam Costin; Georg Ramm; Edouard G Stanley; Andrew G Elefanty; Jennifer L Wilkinson-Berka; Steven Petratos
Journal:  EBioMedicine       Date:  2017-10-19       Impact factor: 8.143

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.